IDYA - Ideaya Biosciences Inc
IEX Last Trade
39.48
0.310 0.785%
Share volume: 379,125
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$39.17
0.31
0.79%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-08 | 2023-03-07 | 2023-05-09 | 2023-08-10 | 2023-11-07 | 2024-02-20 | 2024-05-07 | |
| Assets | |||||||||
| Total Assets | 338.007 M | 410.907 M | 387.969 M | 364.746 M | 527.557 M | 532.942 M | 649.316 M | 961.527 M | |
| Current Assets | 272.189 M | 393.437 M | 370.454 M | 343.958 M | 501.788 M | 482.182 M | 532.632 M | 709.353 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.281 M | 3.744 M | 5.414 M | 4.020 M | 7.912 M | 6.728 M | 7.500 M | 10.566 M | |
| Short Term Investments | 3.281 M | 3.744 M | 5.414 M | 4.020 M | 7.912 M | 6.728 M | 7.500 M | 10.566 M | |
| Total Receivables | 288.000 K | 3.449 M | 211.000 K | 468.000 K | 160.000 K | 6.703 M | 18.000 K | 15.000 K | |
| Current Cash | 268.620 M | 386.244 M | 364.829 M | 339.470 M | 493.716 M | 468.751 M | 525.114 M | 698.772 M | |
| Total Non-current Assets | 65.818 M | 17.470 M | 17.515 M | 20.788 M | 25.769 M | 50.760 M | 116.684 M | 252.174 M | |
| Property Plant Equipment | 7.163 M | 6.679 M | 6.509 M | 6.716 M | 6.829 M | 6.192 M | 6.164 M | 6.909 M | |
| Other Assets | 3.378 M | 2.994 M | 2.583 M | 2.226 M | 1.841 M | 1.452 M | 2.271 M | 1.872 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 338.007 M | 410.907 M | 387.969 M | 364.746 M | 527.557 M | 532.942 M | 649.316 M | 961.527 M | |
| Total liabilities | 68.686 M | 42.138 M | 38.514 M | 30.936 M | 25.948 M | 24.893 M | 28.226 M | 26.216 M | |
| Total current liabilities | 58.089 M | 32.727 M | 31.718 M | 29.820 M | 25.337 M | 24.893 M | 27.101 M | 24.960 M | |
| Accounts Payable | 4.227 M | 3.645 M | 4.280 M | 4.376 M | 5.868 M | 5.169 M | 6.598 M | 6.290 M | |
| Other liabilities | 8.025 M | 7.314 M | 5.185 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 1.783 M | 1.827 M | 1.871 M | 1.915 M | 1.961 M | 2.097 M | 1.747 M | 1.151 M | |
| Long term debt | 2.572 M | 2.097 M | 1.611 M | 1.116 M | 611.000 K | 0.000 | 1.125 M | 1.256 M | |
| Other liabilities | 8.025 M | 7.314 M | 5.185 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 269.321 M | 368.769 M | 349.455 M | 333.810 M | 501.609 M | 508.049 M | 621.090 M | 935.311 M | |
| Common stock | 38.661 M | 40.302 M | 48.224 M | 48.370 M | 56.251 M | 59.999 M | 65.459 M | 75.108 M | |
| Retained earnings | -212.817 M | -211.202 M | -235.403 M | -259.043 M | -286.969 M | -314.409 M | -348.364 M | -387.936 M |